Skip to main content
TipRanks
Go Ultimate75% OFF

Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis

2 Followers
IN:FAIRCHEMOR

Fairchem Organics Ltd

(NSE:FAIRCHEMOR)

Select Model
Rating:53Neutral
Price Target:INR 672.00▲(2.80% Upside)
Action:reiterated
Date:10/14/26

The overall score is heavily weighed down by severe fundamental weaknesses and stretched valuations, despite exceptionally strong technical momentum. The most impactful risks are drastic margin erosion and a high P/E ratio, while positive price trends remain the primary supportive factor for the stock.

Positive Factors
Manageable LeverageModerate leverage gives Fairchem Organics financial flexibility to continue operating and invest without excessive debt pressure. Although leverage has risen, the current debt-to-equity level remains manageable, supporting resilience if profitability takes time to recover.
Negative Factors
Revenue and Margin DeteriorationDeclining revenue combined with sharp margin compression weakens the company’s current earnings base and reduces resources available for reinvestment. The deterioration also suggests that costs, pricing, or product mix are constraining profitability relative to the stronger FY2021–FY2024 period.

Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%30%IN:FAIRCHEMOR-0.41%INDA-4.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 8.23B
Dividend Yield
0.15%
Average Volume (3M)
2,981
Price to Earnings (P/E)
34.9
Beta (1Y)
0.02
Revenue Growth
17.44%
EPS Growth
304.08%
Country
India
Employees
212
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Fairchem Organics Ltd Business Overview & Revenue Model

Company Description

Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across India...

Fairchem Organics Ltd Financial Statement Overview

Summary

Financial performance is significantly impaired by severe margin compression, ongoing revenue declines, and a plummeting Return on Equity. A recent return to positive cash generation and manageable debt levels provide some stabilization against these operational headwinds.

Income Statement

15Very Negative

Balance Sheet

48Neutral

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.60B4.60B5.38B6.21B6.47B6.42B
Gross Profit642.92M355.37M666.52M1.54B1.56B1.78B
EBITDA446.72M220.40M441.21M681.10M729.68M1.05B
Net Income237.76M55.41M219.74M405.00M435.01M679.06M
Balance Sheet
Total Assets3.98B3.91B4.02B3.34B3.42B3.24B
Cash, Cash Equivalents and Short-Term Investments14.24M12.26M12.86M84.00K838.00K83.00K
Total Debt702.35M837.82M630.32M73.18M501.68M620.30M
Total Liabilities1.17B1.28B997.98M443.77M831.48M919.26M
Stockholders Equity2.82B2.63B3.02B2.90B2.59B2.32B
Cash Flow
Free Cash Flow0229.13M-464.87M563.52M348.89M58.91M
Operating Cash Flow0382.54M-203.78M744.80M496.15M404.85M
Investing Cash Flow0-140.95M-255.71M-176.25M-144.92M-341.84M
Financing Cash Flow0-241.53M459.49M-568.55M-351.24M-63.19M

Fairchem Organics Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price653.70

Price Trends

50DMA681.82Negative
100DMA698.16Negative
200DMA638.77Positive

Market Momentum

MACD-9.65Positive
RSI43.98Neutral
STOCH23.63Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Negative. The current price of 653.70 is below the 20-day moving average (MA) of 682.62, below the 50-day MA of 681.82, and above the 200-day MA of 638.77, indicating a neutral trend. The MACD of -9.65 indicates Positive momentum. The RSI at 43.98 is Neutral, neither overbought nor oversold. The STOCH value of 23.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FAIRCHEMOR.

Fairchem Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:FAIRCHEMOR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:ATULIN:ATUL68NeutralINR 149.07B19.31―0.59%18.15%42.38%
IN:ALKYLAMINEIN:ALKYLAMINE61NeutralINR 80.54B32.52―0.64%13.38%35.82%
IN:JUBLINGREAIN:JUBLINGREA61NeutralINR 91.41B25.83―0.87%15.41%21.76%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:FAIRCHEMORIN:FAIRCHEMOR53NeutralINR 8.23B34.94―0.15%17.44%304.08%
IN:AARTIINDIN:AARTIIND47NeutralINR 165.88B28.02―0.22%39.85%103.71%
IN:LXCHEMIN:LXCHEM46NeutralINR 42.80B24.88―0.19%21.34%105.39%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%IN:FAIRCHEMORIN:AARTIINDIN:ALKYLAMINEIN:ATULIN:JUBLINGREAIN:LXCHEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:FAIRCHEMOR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:FAIRCHEMORFairchem Organics Ltd653.70-17.09-2.55%
IN:AARTIINDAARTI Industries Ltd457.3073.4119.12%
IN:ALKYLAMINEAlkyl Amines Chemicals Limited1574.65-157.23-9.08%
IN:ATULAtul Limited5063.35-882.84-14.85%
IN:JUBLINGREAJubilant Ingrevia Ltd.573.90-140.88-19.71%
IN:LXCHEMLaxmi Organic Industries Ltd.154.00-28.49-15.61%

Fairchem Organics Ltd Corporate Events

Fairchem Organics Confirms Full Demat Compliance Under SEBI Rules

Oct 7, 2026

Fairchem Organics Ltd has reported to the NSE and BSE that it has obtained the required confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The filing...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 14, 2026